Vaxcyte, Inc. Stock News

SAN CARLOS, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequ

SAN CARLOS, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the conseque

SAN CARLOS, Calif., April 05, 2022 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the conseq

Vaxcyte, Inc. (PCVX) CEO Grant Pickering on Q4 2021 Results - Earnings Call Transcript

SAN CARLOS, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacter

SAN CARLOS, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacter

The stock price of Vaxcyte Inc (NASDAQ: PCVX) fell by 9.5% in the most recent trading session. This is why it happened.

Vaxcyte Inc (NASDAQ: PCVX ) priced its previously announced offering of common stock and pre-funded warrants at $20.00 per share, and $19.999 per underlying share, respectively. Vaxcyte is selling 2.5 million shares and pre-funded warrants to purchase 2.5 million shares of common stock in the offering. The aggregate gross proceeds to Full story available on Benzinga.com

Vaxcyte Inc (NASDAQ: PCVX) priced its previously announced offering of common stock and pre-funded warrants at $20.00 per share, and $19.999 per underlying share, respectively. Vaxcyte is selling 2

Vaxcyte (PCVX) has priced its public offering of 2.5M shares of common stock and pre-funded warrants to purchase equal number of shares.The shares and pre-funded warrants are being sold

Gainers: Puma Biotechnology PBYI +16%, Marin Software (MRIN) +9%, Midland States Bancorp (MSBI) +6%, IDEAYA Biosciences (IDYA) +3%, Ironwood Pharmaceuticals (IRWD) +3%.Losers:…

Vaxcyte (PCVX) starts the direct offering of its common stock and pre-funded warrants where underwriters are to be granted an additional 15% overallotment option. Actual size, price

The average of price targets set by Wall Street analysts indicates a potential upside of 96.5% in Vaxcyte, Inc. (PCVX). While the effectiveness of this highly sought-after metric is questionable, the

Sutro; A Biotech To Watch With A Catalyst Rapidly Approaching

Vaxcyte, Inc. (NASDAQ:PCVX) VP Jeff Fairman sold 4,619 shares of the stock in a transaction dated Thursday, December 16th. The shares were sold at an average price of $22.50, for a total value of $103,927.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. []